Sterne Kessler Goldstein Fox

Media + Events

No Data, No Patent?- Establishing A Credible Utility For Therapeutic Method Patents

03.10.10 Eldora L. Ellison and Cynthia M. Bouchez, Financier Worldwide's 2010 Biotechnology & Life Sciences Sector e-book

In this article, Eldora Ellison and Cynthia Bouchez address two questions that commonly face applicants for US patents: ‘When should I file my patent application?’ and ‘What information should I include in my patent application?’ A recent decision by the US Court of Appeals for the Federal Circuit (CAFC), the court that hears patent appeals, may affect the answers to these questions for applicants who seek to patent therapeutic methods.

Related Industries

Related Services

Related People

(1) Recent Headlines

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

09.08.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Today we announced the expansion of our Trademark Practice with the addition of Monica Riva Talley, a veteran trademark attorney and law firm partner with more than 14 years of experience.

Sterne Kessler Adds Trademark Partner from Finnegan Henderson

09.07.10 Jeff Jeffrey, The Blog of Legal Times

SKGF Named Finalist for Digital PR Award for The Reexamination Center

SKGF Named Finalist for Digital PR Award for The Reexamination Center

08.13.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Sterne, Kessler, Goldstein & Fox has been named a finalist in PR News’ Digital PR Awards program in the Microsite/Custom Site category for The Reexamination Center, the first comprehensive website providing news, events, education, and analysis on all aspects of patent reexaminations.

New U.S. Biosimilar Act has Important Implications for Patent Licensing

New U.S. Biosimilar Act has Important Implications for Patent Licensing

08.04.10 Timothy J. Shea & Christine F. Norris, Sterne, Kessler, Goldstein & Fox P.L.L.C.

Timothy Shea and Christine Norris discuss the ramifications for patent licensing created by the passage of The Biologics Price Competition and Innovation Act, signed into law in March 2010.

(2) Upcoming Events

Workshop on Tensor Decompositions and Applications
James Raynolds will present "An Algebraic Approach to Optimizing Tensor Operations in MATLAB (and other production languages interpreted or compiled)".

Media Contact

Erin S. West Communications and Marketing Manager

p 202.772.8878   f 202.371.2540

email